TAM
HAE icon

Tealwood Asset Management’s Haemonetics HAE Stock Holding History

Tealwood Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$1.36M Sell
12,279
-58
-0.5% -$7.18K 0.54% 84
2020
Q4 		$1.47M Sell
12,337
-907
-7% -$97.6K 0.69% 53
2020
Q3 		$1.16M Buy
13,244
+4,090
+45% +$357K 0.75% 51
2020
Q2 		$820K Buy
+9,154
New +$925K 0.55% 80

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tealwood Asset Management's HAE Position: Q1 2021 in Review

Tealwood Asset Management reduced its Haemonetics (HAE) stake by 0.47% in Q1 2021, selling an estimated $7.18K and leaving 12,279 shares worth $1.36M. The position accounts for 0.54% of the portfolio, ranked #84.

Tealwood Asset Management first reported a position in HAE in Q2 2020 and has held it in 4 quarters since. The position peaked at $1.47M in Q4 2020. 296 funds tracked by Wall St. Rank hold HAE as of Q1 2021.

  • Tealwood Asset Management held 12,279 shares of Haemonetics worth $1.36M as of Q1 2021.
  • Tealwood Asset Management sold 58 Haemonetics shares in Q1 2021, an estimated $7.18K.
  • Haemonetics made up 0.54% of Tealwood Asset Management's portfolio in Q1 2021, its #84 holding.
  • Tealwood Asset Management first reported a position in Haemonetics in Q2 2020 and has held it in 4 quarters since.
  • Tealwood Asset Management's Haemonetics position peaked at $1.47M in Q4 2020.
  • 296 funds tracked by Wall St. Rank held Haemonetics as of Q1 2021.

Based on Tealwood Asset Management's 13F filing for Q1 2021, filed 21 Jun 2021.